Summary

The roots of electrocardiography trace back to the early 20th century when Dutch physiologist Willem Einthoven developed the first practical ECG machine. Since then, technological innovations have propelled ECG devices into the digital age, revolutionizing how we understand and manage heart health. Early ECG devices utilized analog technology, recording heart signals on paper. The advent of digital technology marked a significant leap forward, enabling more accurate and accessible data interpretation. Digital ECG devices offer real-time monitoring, data storage, and remote access to healthcare professionals. Modern ECG devices have become increasingly compact and portable. This evolution has facilitated the development of wearable and handheld ECG monitors, empowering individuals to monitor their heart health outside traditional clinical settings. Wearables, such as smartwatches and patches, have become popular tools for continuous heart rate monitoring. Connectivity has become a cornerstone of ECG device development. Wireless technology allows seamless data transfer between the device and electronic health records (EHRs), promoting efficient healthcare delivery. This connectivity also enables remote patient monitoring, enhancing patient care and reducing the burden on healthcare systems. Electrocardiography is a method of generating an electrocardiogram ECG or EKG which records the electrical activity of the heart to detect any small kind of changes in the cardiac cycle. The appearance of changes in the cardiac cycle during ECG signifies the presence of various heart abnormalities such as atrial fibrillation, myocardial ischemia, and myocardial infarction. Changing lifestyle, high-stress level, smoking, and obesity are some of the risk factors associated with heart diseases. ECG devices can help in early diagnosis of a variety of cardiac diseases. Wearable Holter monitors and handheld ECG devices are mainly used to monitor the heart rhythm. Increasing prevalence of cardiac arrest and widespread awareness about the early diagnosis of heart diseases are anticipated to fuel the growth of ECG devices market during the forecast period.

According to the research report, “Global Electrocardiograph (ECG) Market Overview, 2023-28” published by Bonafide Research, the Global market is anticipated to cross USD 12 Billion by 2028, increasing from USD 8.76 Billion in 2022. The market is expected to grow with more than 5% CAGR by 2023-28. The widespread adoption of ECG devices has had a profound impact on healthcare, influencing diagnostics, treatment strategies, and patient outcomes. ECG devices play a crucial role in the early detection of cardiovascular abnormalities. Regular monitoring enables healthcare professionals to identify irregularities and intervene before more serious conditions develop. This proactive approach can lead to better outcomes and reduced healthcare costs. The rise of telemedicine and remote patient monitoring has been accelerated by the integration of ECG devices. Patients can now participate in virtual consultations, and healthcare providers can monitor their cardiac health in real-time. This is particularly beneficial for individuals with chronic conditions, as it allows for timely interventions and adjustments to treatment plans. The digital nature of modern ECG devices generates vast amounts of data. Machine learning and artificial intelligence algorithms can analyze this data to identify patterns and trends that may go unnoticed by human observers. This data-driven approach holds promise for more personalized and effective treatment strategies. The Electrocardiograph market has been impacted by Covid-19, which includes a significant drop in Electrocardiograph sales due to a lack of visits to healthcare facilities such as hospitals and clinics. The spread of the coronavirus also has an impact on workforce and staffing issues, as well as procedural prioritization. These factors have influenced the Electrocardiograph market by causing cancellation of primary care appointments at hospitals and reflecting patients' concerns about infection.

The Asia-Pacific region is experiencing substantial growth in the ECG (Electrocardiography) Devices Market due to a confluence of several factors. Firstly, the increasing prevalence of cardiovascular diseases in the region has heightened the demand for advanced diagnostic tools, with ECG devices playing a pivotal role in the timely detection and management of cardiac conditions. The rise in lifestyle-related risk factors, such as sedentary lifestyles, poor dietary habits, and stress, has contributed to a surge in cardiovascular ailments, necessitating a robust infrastructure for cardiac care. Secondly, rapid economic development and urbanization in several Asia-Pacific countries have led to improved healthcare infrastructure and increased access to medical facilities. This has facilitated the adoption of advanced medical technologies, including state-of-the-art ECG devices, across urban and rural healthcare settings. Thirdly, the growing awareness of preventive healthcare measures and an increasing focus on regular health check-ups have encouraged individuals to seek early detection of potential cardiac issues, driving the demand for ECG monitoring. Additionally, advancements in technology, including the integration of artificial intelligence in ECG analysis and the development of portable and wearable ECG devices, have captured the attention of healthcare providers and consumers alike. The Asia-Pacific region has embraced these technological innovations, further propelling the growth of the ECG devices market. Lastly, supportive government initiatives, rising healthcare expenditure and an expanding aging population have collectively contributed to an encouraging market to thrive. As healthcare systems in the region continue to evolve, the emphasis on cardiovascular health and the adoption of cutting-edge medical technologies are likely to sustain and amplify the upward trajectory of the ECG devices market in the Asia-Pacific region.

Event Recorders, also known as cardiac event monitors, have gained prominence due to their ability to provide continuous and on-demand monitoring of the heart's electrical activity over an extended period. One key driver is the increasing emphasis on ambulatory and remote patient monitoring, particularly for individuals with intermittent or sporadic symptoms of cardiac arrhythmias or other cardiovascular conditions. Event Recorders offer a convenient solution for capturing infrequent symptoms, allowing for a more accurate diagnosis compared to traditional short-duration ECG recordings. Moreover, the aging population and the rising incidence of cardiovascular diseases have heightened the demand for efficient and patient-friendly diagnostic tools. Event Recorders, often in the form of compact and wearable devices, empower individuals to record and transmit ECG data easily, promoting early detection and intervention. Technological advancements have played a pivotal role in the growth of Event Recorders, with many devices now equipped with features such as wireless connectivity and automated data transmission to healthcare providers. The integration of smart technology and connectivity enables real-time monitoring, enhancing the efficiency of healthcare delivery and allowing for timely interventions. Event Recorders align with the broader trend of patient-centric care and the shift towards proactive healthcare management. As healthcare systems worldwide embrace digital transformation, the versatility, ease of use, and diagnostic accuracy offered by Event Recorders contribute significantly to their growing adoption in the ECG devices market.

The growing prominence of ECG (Electrocardiography) Devices in home settings and Ambulatory Surgical Centers (ASCs) is a reflection of the broader trends in healthcare that prioritize accessibility, convenience, and cost-effectiveness. In home settings, the increasing adoption of ECG devices is driven by a shift towards patient-centric care and the recognition of the importance of continuous monitoring, especially for individuals with chronic cardiovascular conditions. Home-based ECG devices empower patients to monitor their heart health in real-time, promoting early detection of abnormalities and facilitating timely interventions. This trend aligns with the broader movement towards telehealth and remote patient monitoring, which gained significant momentum, particularly in the wake of the COVID-19 pandemic. The convenience of conducting ECG tests at home not only improves patient compliance but also reduces the burden on healthcare facilities. Simultaneously, the integration of ECG devices in Ambulatory Surgical Centers (ASCs) reflects the increasing preference for outpatient care models. ASCs provide a setting where patients can receive surgical and diagnostic services without the need for hospitalization, thereby reducing costs and improving efficiency. The inclusion of ECG devices in ASCs is particularly relevant for preoperative assessments, as they allow for quick and accurate cardiac evaluations before surgical procedures. Portable and user-friendly ECG devices enable healthcare providers in ASCs to perform on-the-spot cardiac assessments, contributing to streamlined workflows and ensuring the safety of patients undergoing outpatient surgeries. The advancements in technology, such as the development of compact and wireless ECG devices, further facilitate their integration into these settings.

The growing prominence of 12-Lead ECG in the ECG (Electrocardiography) Devices Market can be attributed to its enhanced diagnostic capabilities and the increasing recognition of its clinical value in providing a more comprehensive assessment of cardiac activity. A 12-Lead ECG records electrical signals from the heart from 12 different perspectives or "leads," offering a more detailed and accurate representation of the heart's electrical activity compared to standard 3-Lead or 5-Lead ECGs. This expanded data capture is particularly beneficial in identifying specific cardiac abnormalities, such as ischemia, infarction, and arrhythmias, which might not be as apparent in a more limited lead configuration. As healthcare professionals strive for a more precise and nuanced understanding of cardiac conditions, the demand for 12-Lead ECG devices has surged. The versatility of 12-Lead ECG is another factor fueling its growth. The comprehensive data it provides is essential not only in diagnosing acute conditions but also in ongoing monitoring and management of chronic cardiovascular diseases. Additionally, the adoption of 12-Lead ECG in pre-hospital and emergency care settings has become pivotal, as it enables rapid and accurate assessments of patients experiencing chest pain or other cardiac symptoms. The real-time information obtained from a 12-Lead ECG assists healthcare providers in making timely decisions, such as initiating appropriate interventions or directing patients to specialized care. Furthermore, technological advancements have played a significant role in the integration of 12-Lead ECG devices into various healthcare settings. The development of portable and wireless 12-Lead ECG devices enhances their usability in diverse environments, including emergency response vehicles, ambulances, and remote healthcare settings. These devices offer the flexibility to conduct comprehensive cardiac assessments beyond traditional clinical settings, aligning with the broader trend of decentralizing healthcare delivery.

The burgeoning growth of Wireless ECG Systems in the ECG (Electrocardiography) Devices Market can be attributed to a confluence of technological advancements, changing healthcare paradigms, and the increasing emphasis on patient-centric care. Wireless ECG Systems represent a transformative shift from traditional wired systems, offering unparalleled flexibility and mobility in cardiac monitoring. The elimination of cumbersome wires allows patients to undergo continuous ECG monitoring without the constraints of being physically tethered to a monitoring device. This newfound freedom aligns with the broader trend of remote patient monitoring and telehealth, where patients can seamlessly integrate cardiac monitoring into their daily lives. The advent of wireless technology has facilitated real-time data transmission and connectivity, enabling healthcare providers to receive instant ECG readings from patients regardless of geographical distances. This is particularly crucial in the context of remote and underserved areas, where access to healthcare facilities may be limited. The convenience and ease of use associated with Wireless ECG Systems contribute to early detection of cardiac abnormalities, promoting proactive healthcare management and reducing the risk of complications. Moreover, the integration of Wireless ECG Systems with mobile applications and cloud-based platforms has further propelled their growth. Patients can use wearable devices equipped with wireless ECG capabilities, and the collected data can be securely transmitted to healthcare providers for analysis and interpretation. This not only fosters a continuous feedback loop between patients and healthcare professionals but also enhances the overall efficiency of the diagnostic process.

The growth of the ECG (Electrocardiography) Devices Market in response to the rising prevalence of Cardiovascular Disorders and Hypertension can be attributed to the critical role these devices play in the diagnosis, management, and monitoring of these pervasive health conditions. Cardiovascular disorders, encompassing a spectrum of diseases such as coronary artery disease, heart failure, and arrhythmias, have witnessed a surge in incidence globally. Hypertension, a leading risk factor for cardiovascular diseases, has become a widespread public health concern. As these conditions become more prevalent, the demand for advanced diagnostic tools, including ECG devices, has escalated. ECG devices are integral in the diagnosis of various cardiovascular disorders, providing a non-invasive and efficient means of assessing the heart's electrical activity. The ability of ECGs to detect abnormalities in rhythm, conduction, and structure enables healthcare professionals to make accurate diagnoses and formulate appropriate treatment plans. In the case of hypertension, ECGs are instrumental in identifying associated complications such as left ventricular hypertrophy and other structural changes in the heart. Furthermore, ECG devices play a pivotal role in the continuous monitoring of patients with cardiovascular disorders and hypertension. The trend towards wearable ECG devices and remote monitoring solutions has gained momentum, allowing individuals to track their heart health in real-time. This continuous monitoring is particularly valuable for early detection of anomalies, enabling timely interventions and personalized management strategies.

Market Drivers

• Aging Population and Chronic Diseases: The global aging population is prone to chronic diseases, including cardiovascular conditions. As the demographic of elderly individual’s increases, there is a corresponding rise in the demand for diagnostic tools such as ECG devices to manage and monitor age-related cardiovascular issues.

• Increased Awareness and Preventive Healthcare: Growing awareness of cardiovascular health and the importance of preventive healthcare are driving individuals to seek regular health check-ups. This proactive approach towards health, coupled with increasing health consciousness, contributes to the demand for ECG devices for routine screenings and early detection of cardiac abnormalities.

Market Challenges

• Data Security and Privacy Concerns: The integration of ECG devices with digital platforms and healthcare information systems raises concerns about data security and privacy. Ensuring the secure transmission and storage of sensitive patient information poses a challenge, especially in the context of increasing cyber threats and regulatory requirements for safeguarding patient data.

• High Cost of Advanced ECG Technologies: While technological advancements bring sophisticated features to ECG devices, the associated costs can be a challenge, limiting accessibility for certain healthcare facilities and patients. Striking a balance between incorporating advanced technologies and maintaining affordability is a challenge for manufacturers.

Market Trends

• Point-of-Care (POC) and Handheld ECG Devices: There is a trend towards the development of compact, handheld, and point-of-care ECG devices. These devices offer convenience for healthcare professionals in various settings, including clinics and emergency departments, enabling quick and on-the-spot cardiac assessments.

• Wearable ECG Technology: The market is witnessing a surge in wearable ECG technology, including smartwatches and fitness trackers with built-in ECG monitoring capabilities. This trend aligns with the broader consumer trend of incorporating health monitoring features into wearable devices for continuous and real-time tracking.

• Global Health Crisis Preparedness: Recent global health crises, such as the COVID-19 pandemic, have emphasized the need for robust healthcare infrastructure and remote monitoring capabilities. ECG devices play a crucial role in such scenarios, and the trend toward strengthening healthcare systems for crisis preparedness is likely to impact the market positively.

Competitive Landscape

The global ECG devices market is consolidated, with a few key players accounting for a major share. Most companies are making significant investments in research & development activities. Expansion of product portfolios and mergers & acquisitions are the key strategies adopted by the players. Key players operating in the market include Koninklijke Philips N.V. , GE HealthCare Technologies, Inc., Midmark Corporation, Schiller AG, Nihon Kohden Corporation, Biomedical Instruments Co., Ltd., Baxter International Inc., Medline Industries, EDAN Instruments, Inc., Applied Cardiac Systems, Fukuda Denshi Co Ltd , OSI Systems, Inc., Mindray Medical International Limited , Bittium Corporation, EB Neuro S.p.A. and Omron Corporation.

Key Developments

• In February 2022, AliveCor launched the KardiaMobile Card, the slimmest, most convenient personal ECG device in the United States. It is the only personal ECG slim enough to fit in a wallet for instant feedback on heart health anytime, anywhere.

• In January 2022, Philips introduced the industry's first full-service, at-home, 12-lead electrocardiogram (ECG) solution for use in decentralized clinical trials.

• In April 2022, Biotricity officially launched the commercial sales of its FDA-cleared wireless wearable cardiac monitoring device, Biotres. The product has been available for pre-order to physicians, medical offices, hospitals, and individual use since late February 2022.

• In January 2022, Philips announced the industry's first full-service, at-home 12-lead electrocardiogram (ECG) solution for usage in decentralized clinical trials. The clinical-grade solution is the company's most sophisticated patient-centric ECG product, combining data readings that are equivalent to clinical, site-based ECGs with Philips' leading cloud-based data gathering and analysis capabilities. This latest addition to Philips' digitally enabled monitoring solution suite aids in driving innovation across the care continuum and supports decentralized clinical trials.

Considered in this report:

• Geography: Global
• Historic year: 2017
• Base year: 2022
• Estimated year: 2023
• Forecast year: 2028

Aspects covered in this report:

• Global Electrocardiograph (ECG) market with its value and forecast along with its segments
• Region-wise Electrocardiograph (ECG) market analysis
• Various drivers and challenges
• On-going trends and developments
• Top profiled companies
• Strategic recommendation

Regions covered in the report

• North America
• Europe
• Asia-Pacific
• South America
• Middle-East & Africa

By Product:

• Resting Electrocardiograph (ECG)
• Stress Electrocardiograph (ECG)
• Holter Monitors
• Event Recorders
• Others

By End User:

• Hospitals & Clinics
• Home Settings & Ambulatory Surgical Centers (ASCs)
• Others

By Lead type:

• 6-Lead ECG
• 12-Lead ECG
• 3-Lead ECG
• 2-Lead ECG
• Single Lead ECG

By Technology:

• Portable ECG System
• Wireless ECG System

By Indication:

• Cardiovascular Disorders & Hypertension
• Cancer
• Diabetes
• Respiratory Diseases
• Pregnancy
• Movement Disorders
• Wound Care
• Hearing Disorders
• Other Indications (sleep disorders, kidney disorders, neurovascular diseases, and HIV)

The approach of the report:

This report consists of a combined approach of primary as well as secondary research. Initially, secondary research was used to get an understanding of the market and list out the companies that are present in the market. The secondary research consists of third-party sources such as press releases, and annual reports of companies, analyzing the government-generated reports and databases. After gathering the data from secondary sources primary research was conducted by making telephonic interviews with the leading players about how the market is functioning and then conducting trade calls with dealers and distributors of the market. Post this we have started doing primary calls to consumers by equally segmenting consumers into regional aspects, tier aspects, age groups, and gender. Once we have primary data with us we started verifying the details obtained from secondary sources.

Intended audience:

This report can be useful to industry consultants, manufacturers, suppliers, associations & organizations related to the Electrocardiograph (ECG) industry, government bodies, and other stakeholders to align their market-centric strategies. In addition to marketing & presentations, it will also increase competitive knowledge about the industry.








***Please Note: It will take 48 hours (2 Business days) for delivery of the report upon order confirmation.

ページTOPに戻る

Table of Contents